Patent details

Basic Information

Publication number:

EP3881841

PCT Application Number:

JP2019044851

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP198845844

PCT Publication Number:

WO2020101013

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITION

French Title of Invention:

COMPOSITION PHARMACEUTIQUE

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNG

SPC Number:

Dates

Filing date:

15/11/2019

Grant date:

18/10/2023

EP Publication Date:

22/09/2021

PCT Publication Date:

22/05/2020

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/10/2023

EP B1 Publication Date:

18/10/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

15/11/2023

Expiration date:

15/11/2039

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/10/2023

 

 

Name:

Seikagaku Corporation

Address:

6-1, Marunouchi 1-chome Chiyoda-ku, Tokyo 100-0005, Japan (JP)

Inventor

1

Name:

TAKAHATA, Chiaki

Address:

Japan (JP)

2

Name:

YAMASHITA, Naoya

Address:

Japan (JP)

3

Name:

HOSHI, Hirotaka

Address:

Japan (JP)

4

Name:

KUNII, Naoko

Address:

Japan (JP)

Priority

Priority Number:

2018215867

Priority Date:

16/11/2018

Priority Country:

Japan (JP)

Classification

IPC classification:

A61K 31/196; A61P 29/00; A61K 47/10; A61K 47/20; A61K 47/22; A61K 47/26; A61K 47/32; A61K 47/40; A61K 47/55; A61K 47/61; A61K 9/08;

Publication

European Patent Bulletin

Issue number:

202342

Publication date:

18/10/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages